Panbela Therapeutics, Inc. — Form D
Panbela Therapeutics, Inc. of Waconia, MN, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-29. $8.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-06-29
- Form: D
- Accession: 0001437749-22-016182
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $8.8M
- Investors: 70
- Date of first sale: 2022-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450719
Issuer
- Name: Panbela Therapeutics, Inc.
- CIK: 0001029125
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 712 Vista Blvd #305, Waconia, MN, 55387
- Phone: 952-479-1196
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Daniel T Donovan | Director | Waconia, MN |
| Robert D Schemel | Director | Waconia, MN |
| J. Robert Paulson | Director | St. Paul, MN |
| J. Robert Paulson, Jr. | Director | PLYMOUTH, MN |
| Daniel S Donovan | Director | Waconia, MN |
| Susan K Horvath | Executive Officer | Waconia, MN |
| Arthur J Fratamico | Director | Waconia, MN |
| Robert S Schemel | Director | Waconia, MN |
| Susan M Horvath | Executive Officer | Waconia, MN |
| Jennifer K Simpson | Director | New York, NY |
| Jennifer K Simpson | Executive Officer | New York, NY |
| D. ROBERT SCHEMEL | Director | WACONIA, MN |
| SCOTT ROBERT KELLEN | Executive Officer | WACONIA, MN |
| Jeffrey S Mathiesen | Director | Eden Prairie, MN |
| Suzanne T Gagnon | Director | Waconia, MN |
| Paul W Schaffer | Director | Waconia, MN |
| David B Kaysen | Director | Waconia, MN |
| David B Kaysen | Executive Officer | Waconia, MN |
| Michael T Cullen | Director | Waconia, MN |
| Michael T Cullen | Executive Officer | Waconia, MN |
| Dalvir S Gill | Director | Waconia, MN |
| Jeffrey E Jacob | Director | Tucson, AZ |
Other filings by this issuer (7)
More